Pure Global AI
ANVISA registration 10339840563Valid until May 05, 2035

PROSTATE-SPECIFIC ANTIGEN (PSA)

ANVISA Registration Number: 10339840563DIASORIN LTDADIASORIN ITALIA S.P.A.Risk Class III
Device names
Technical name
PROSTATE-SPECIFIC ANTIGEN (PSA)
PT: ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)
Commercial name
Família LIAISON® PSA II Gen
Risk class
Class III
Registration details
Registration Number
10339840563
Process Number
25351457905202484
CNPJ
01896764000170
Company information
Registration Holder
DIASORIN LTDA
Manufacturing Country
Italy
PT: ITÁLIA
Dates and status
Publication Date
May 05, 2025
Validity
05/05/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for PROSTATE-SPECIFIC ANTIGEN (PSA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840563 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until May 05, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.